Chinook Therapeutics Inc Cvr (ADRO)
Deferred Revenue
$3.79M
Quarterly · Period ending: · USD
ADRO Deferred Revenue
Latest reported$3.79Mperiod ending
Latest reported$3.79Mperiod ending
ADRO Quarterly Deferred Revenue ($33.43M → $3.79M)
Quarterly deferred revenue
High-resolution chart · PNG
ADRO deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 3,786,000 | |
| 4,935,000 | |
| 5,808,000 | |
| 6,950,000 | |
| 16,000,000 | |
| 16,000,000 | |
| 16,000,000 | |
| 16,000,000 | |
| 17,744,000 | |
| 17,613,000 | |
| 14,882,000 | |
| 14,923,000 | |
| 14,945,000 | |
| 14,945,000 | |
| 14,983,000 | |
| 15,052,000 | |
| 15,164,000 | |
| 15,171,000 | |
| 15,046,000 | |
| 15,046,000 | |
| 19,732,000 | |
| 17,754,000 | |
| 26,947,000 | |
| 33,427,000 |